The answer is divided into generic questions and food, cosmetics, pharmaceuticals, medical treatment and radiating-education project.
No. Facilities registration, product listing or radiation product reporting is used primarily to submit specific information and does not automatically represent the listing of products approved, licensed or approved by FDA. The required pre-marketing process depends on the product type, use and applicable path. But look first.FDA Basic Note on RegistrationAnd check it out.FDA description of the registration and approval of instruments。
It cannot all be considered as a “FDA certificate” or product approval certificate. Registration and listing of equipment does not constitute approval; The cosmetics facility registration number or the product listing does not indicate FDA approval; The NDC catalogue also contains information that does not amount to approval or that is verified by the FDA. The recognition of records in different systems has different uses and should be understood as corresponding. See the FDA aboutRegistration and listing of cosmeticsandRegistration and listing of medicinesNote.
No. The type of product regulation, intended use and labeling are to be confirmed before the activities actually performed by the enterprise or facility, the role of responsibility and the applicability of the exemption. Different categories of “registered” “listed” “listed” “pre-listed declaration” and maintenance requirements are not identical.
Suggested first preparation: product name, purpose and label/declaration; The formulation, specifications or technical characteristics; Information on manufacturing and packaging facilities; Business roles such as manufacturers, branders, importers, etc.; Target market and current phase; Registers, listings, declarations or FDA transaction records are available. Information may be provided on a full-time basis, beginning with information known and points to be confirmed.
It cannot be said in general terms that all FDA matters must be entrusted to a third party. In the case of registration of food facilities, the FDA expressly states that it does not require the facilities to use third-party registrants; The need for U.S. agent, system authority or professional declaration support for other matters is determined by the respective rules. The applicable requirements are confirmed before a decision is made on whether to handle or commission the service. See?FDA Q & Answer on Food Facility Registration。
No. The FDA user fee applies only to specific projects or procedures, and the amount and annual arrangements are based on the latest announcement of the FDA counterpart plan; Service costs depend on the agreed terms of reference, information and modalities of collaboration. The consultation should identify official costs, third party costs and service fees separately and not apply a category of costs to all products. But look at the station first.FDA Cost description。
There is no uniform time frame applicable to all products and matters. The time required will be affected by path categories, information integrity, systematic processing, official review procedures and additional communication. Facilities registration, annual information maintenance and pre-market review are not the same process; A project should be identified in such a way that the expected work cycle is communicated separately from the FDA review/processing time.
FDA’s regulatory decisions, import clearances or the results of business platform audits cannot be committed. The service provider may be responsible for the collation, declaration assistance and communication of the information identified by both parties, but the final outcome will depend on the regulatory requirements, product facts, submission of information and decisions of the competent authority/platform. The delegation of authority shall be preceded by a clear written scope, delivery, division of responsibilities and exclusion.
Possibly. Timing and triggers vary by sector. Food facilities renew in even-numbered years. Under MoCRA, cosmetics facility registrations and product listings have separate update cycles. Drug establishments renew annually and update drug listing information in June and December as required. Medical device registration records are maintained under applicable annual and change reporting requirements. Check by category, facility and responsible entity.
The responsibility and time frame for updating is checked after deciding which FDA systems and records are the subject of the changes. Fields, submissions and time frames vary from area to area; Some of the matters may also affect the registration of facilities, the product listing, labels or pre-market declarations. Retention of change dates, supporting documentation, submission of records and confirmation of information.
It is recommended that the submission version, system confirmation/reaction, applicable registration or listing number, account number responsible, follow-up update of records and transactions with FDA be maintained. A return or a number that can support the submission/recording of particular information should not be promoted as FDA approval or certification. Do not share account passwords, personal information or undisclosed business information on public pages or unsafe channels.
No, I won't. The site advice form is used for the submission of consulting information to ALREG and is not the FDA official declaration system; Submission of advice does not automatically create a record of FDA registration or declaration. Please refer to the privacy statement using the form and provide only the information required for the preliminary assessment.
The U.S. food rules usually focus on the registration of eligible food facilities, pre-import Prior Notice, labelling and importer liability; This does not amount to a generic “product register” for every general food product. Specific products and processes may be subject to additional requirements, such as acidified foods or low-acid canned FCE/SID matters. See?FDA Food Facilities Registration DescriptionAnd this station.Guidelines for the registration of food facilities。
Food facilities subject to registration shall be submitted for renewal between 1 October and 31 December of each even-numbered year; Facilities information updates and renewals are different operations. The current published 2026 extension window of the FDA is 1 October to 31 December 2026. Exemptions and individual system arrangementsFDA Current Extension DirectionsSubject.
No. Prior Notice is a notice of shipment provided to FDA prior to the import of food, which differs from the registration of facilities, product regulatory requirements and importer obligations. FDA must receive notification before the arrival of the food at the United States border; Exceptions may apply to certain categories of food products and the timing of their submission has to be checked by mode of transport. See?FDA Human Food Import Requirements。
Not necessarily. U.S. Agent is the communication point between FDA and the facility in the register of foreign food facilities; FSVP importer assumes the applicable supplier certification responsibility. It is possible to do so only if the same subject meets two sets of rules and obtains the corresponding written consent. FSVP is usually borne by the U.S. food owner/consignee; In the absence of such subjects, importers are recognized by the rules. See?FDA FSMA/FSVP FAQAnd this station.FSVP Guide。
(c) The requirement to register a cosmetics manufacturing/processing facility; Responsible Person on the label lists cosmetics sold in the United States and updates product information as required. The registration of facilities is usually renewed every two years, and the information is updated annually; Some small businesses or products/activities may be subject to statutory exemptions, subject to conditions. The registration and listing numbers do not represent FDA approval. For further details, seeFDA MoCRA Registration and Listing NotesAnd this station.MoCRA Guide。
Not normally necessary. Under U.S. law, cosmetics and their components are generally not subject to pre-market approval by the FDA; One of the exceptions is that the colored agent (except the coal tar dye) has to meet the applicable FDA approval requirements. Enterprises still have a responsibility to ensure the safety of products and components and to comply with requirements such as labelling. See?FDA Note on Pre-market Approval of Cosmetics。
Usually the manufacturer, packaging or distributor listed on the product label. Responsible Person is responsible for submitting the required listing information and its updates; This does not imply that it automatically assumes all of the statutory obligations of other enterprises. Specific identity needs to be combined with product labels and business relationship judgements. SeeFDA MoCRA Registration and Listing Notes。
Doesn't mean that. FDA stated that the registration of pharmaceutical businesses, the listing of medicines, the NDC number and the entry to the NDC directory did not provide a separate proof that the product had been approved or that FDA had verified the submission of the information. The appropriate listing route for products needs to be separately identified according to the type and circumstances of the drug. See?FDA NDC Directory DescriptionAnd this station.NDC Guide to Drug Listing。
Pharmaceutical facilities that meet the registration requirements are normally required to renew their annual registration from 1 October to 31 December of each year; Drug listing information is required to be submitted for updating in June and December of each year. The two recorded uses are different and the specific applicability, exemptions and submission fields should be verified as to the activities and products of the facility. See FDAGuide to registration of pharmaceutical facilitiesandDescription of the system for registering and listing medicines。
Not all business names are registered. Facilities involved in pharmaceutical manufacturing, repackaging, relabelling or recycling, and involving commercial distribution in the United States, are usually checked; Specific exemptions are provided for in the statute. The roles of brand parties, licensed applicants, production sites and Labeler should be judged separately. See?FDA Guide to Registration of Pharmaceutical Facilities。
Not necessarily. Registration and listing do not amount to FDA marketing authorization. Products may require 510(k) clearance, PMA approval, De Novo, or may be subject to specific exemptions; Classifications and pathways should first be identified according to the intended use and product characteristics. AvailableOverview of the regulation of FDA devicesAnd this station.Registration and listing of equipment。
No. Most Class I and part of Class II devices are exempt from 510(k), but exemptions may be subject to classification regulations and specific conditions; Even with exemptions of 510(k), other regulatory requirements may still have to be complied with. The FDA product classification database and the corresponding legislation on the device should be checked first and should not be exempt on the sole basis of category names. See?FDA Class I/II statement of exemption。
For equipment manufacturing facilities to be imported into or provided for import into the United States, the FDA requires the designation of U.S. Agent in the facility register. The role mainly assists FDA in communicating with offshore facilities and does not automatically assume reporting obligations for 510(k) declarations or medical events. See?FDA medical statement U.S.A. Agent。
Not necessarily. FDA has independent performance standards, record-keeping and reporting requirements for some of the radiation-launched electronic products; Whether the product belongs to medical device at the same time is judged by reference to the intended use, product category and specific regulations. We'll check first.FDA is a judgement page for radiation-emiting projectAnd this station.Description of the range of radiation products。
That should not be understood. Specific products may require product reports, supplementary reports or other information before entering into interstate commercial circulation; The FDA confirmation of receipt of the report or accession number does not amount to approval or safety certification of the product. Specific reporting types are checked by product category and 21 CFR Part 1002. See?FDA Common Problems in Listing Radiation Products。
Date of content check: 2026-11-04. FDA possible updating of legislation, systems and costs; For specific products, reference should be made to the official FDA and the product facts. General information is provided here and does not constitute a FDA decision or a case legal opinion.
Share intended use, ingredients or technical characteristics, production location, business role and current stage. We can use this information to discuss likely FDA requirements and service scope.